Ramiro Garzon

24.6k citations
142 papers · 13.5k indexed · 6 hit papers · h-index 42
  • Cancer Research top 0.05%
    • MicroRNA in disease regulation 51
    • Cancer-related molecular mechanisms research 26
  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research 57
    • Hematopoietic Stem Cell Transplantation 11
    • RNA Interference and Gene Delivery 21
    • Histone Deacetylase Inhibitors Research 21
    • Circular RNAs in diseases 21
    • RNA modifications and cancer 12
  • Genetics top 1%
  • Immunology top 2%

Ramiro Garzon

138 papers receiving 13.3k citations

Hit Papers

Targeting microRNAs in cancer: rationale, strategies and ...1.2k20062026201220194008001.2k

Peers

Ramiro Garzon
Comparison fields: 5 of 145
  • Cancer Research 8.9k
  • Hematology 2.0k
  • Molecular Biology 10.9k
  • Genetics 774
  • Immunology 1.0k
Replace Leif R. Lund with:
Leif R. Lund Denmark
Amelia Cimmino Italy
Paolo Mignatti United States
Era L. Pogosova‐Agadjanyan United States
Reuven Reich Israel
Sérgio Dias Portugal
Ralph D. Sanderson United States
Yves A. DeClerck United States
Mark D. Sternlicht United States
Elena I. Deryugina United States
Ramiro Garzon relative to Leif R. Lund Denmark Leif R. Lund's profile →
Citations per field
00.5×4.4×
Leif R. Lund · 1×
Citations per year

Countries citing papers authored by Ramiro Garzon

Since Specialization
Citations

This map shows the geographic impact of Ramiro Garzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramiro Garzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramiro Garzon more than expected).

Fields of papers citing papers by Ramiro Garzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramiro Garzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramiro Garzon. The network helps show where Ramiro Garzon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ramiro Garzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ramiro Garzon Line = papers co-authored together Ramiro Garzon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20230
2 20211
3 202027
4 201912
5 201920
6 201833
7 201830
8 20182
9 2017112
10 201747
11 201613
12 201667
13 201653
14 2013151
15 2013154
16 201133
17 201071
18 2009492
19 200717
20
A MicroRNA Signature of Hypoxiabreakdown →
2006890

About Ramiro Garzon

Ramiro Garzon is a scholar working on Hematology, Cancer Research, Molecular Biology, Microbiology and Genetics, having authored 142 papers that have together received 13.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (57 papers), MicroRNA in disease regulation (51 papers), Cancer-related molecular mechanisms research (26 papers), RNA Interference and Gene Delivery (21 papers), Histone Deacetylase Inhibitors Research (21 papers), Circular RNAs in diseases (21 papers), RNA modifications and cancer (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). The work is most often cited by research in Cancer Research (8.9k citations), Hematology (2.0k citations), Molecular Biology (10.9k citations), Genetics (774 citations) and Immunology (1.0k citations). Ramiro Garzon has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Carlo M. Croce, George A. Calin, Guido Marcucci, Muller Fabbri, Stefano Volinia, Hansjüerg Alder, Amelia Cimmino, Michael Andreeff, Nicola Zanesi and Rami I. Aqeilan. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Clinical Cancer Research, Leukemia and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026